Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Haegeman

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Biology|July 1, 1997
Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factorS Plaisance, W Vanden Berghe, E Boone, et al.
The EMBO Journal|August 1, 1993
Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNFK Schulze-Osthoff, R Beyaert, V Vandevoorde, et al.
Receptors & Channels|January 1, 1997
Stable, high-level expression of human serotonin receptors in L929 cells using an inducible expression systemP Vanhoenacker, W Gommeren, W H Luyten, et al.
The Journal of Biological Chemistry|November 5, 1999
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoterW Vanden Berghe, K De Bosscher, E Boone, et al.
European Journal of Biochemistry|September 15, 1986
Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblastsG Haegeman, J Content, G Volckaert, et al.
Molecular Pharmacology|September 25, 1999
Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanismW Vanden Berghe, E Francesconi, K De Bosscher, et al.
British Journal of Pharmacology|August 28, 2014
Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in miceT Saksida, M Vujicic, I Nikolic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibitionV Verhasselt, W Vanden Berghe, N Vanderheyde, et al.
Annals of the Rheumatic Diseases|February 11, 2009
A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistanceV Gossye, D Elewaut, K Van Beneden, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2000
Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cellK De Bosscher, W Vanden Berghe, L Vermeulen, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Biology|July 1, 1997
Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factorS Plaisance, W Vanden Berghe, E Boone, et al.
The EMBO Journal|August 1, 1993
Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNFK Schulze-Osthoff, R Beyaert, V Vandevoorde, et al.
Receptors & Channels|January 1, 1997
Stable, high-level expression of human serotonin receptors in L929 cells using an inducible expression systemP Vanhoenacker, W Gommeren, W H Luyten, et al.
The Journal of Biological Chemistry|November 5, 1999
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoterW Vanden Berghe, K De Bosscher, E Boone, et al.
European Journal of Biochemistry|September 15, 1986
Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblastsG Haegeman, J Content, G Volckaert, et al.
Molecular Pharmacology|September 25, 1999
Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanismW Vanden Berghe, E Francesconi, K De Bosscher, et al.
British Journal of Pharmacology|August 28, 2014
Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in miceT Saksida, M Vujicic, I Nikolic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibitionV Verhasselt, W Vanden Berghe, N Vanderheyde, et al.
Annals of the Rheumatic Diseases|February 11, 2009
A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistanceV Gossye, D Elewaut, K Van Beneden, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2000
Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cellK De Bosscher, W Vanden Berghe, L Vermeulen, et al.
Pageof 6